181 related articles for article (PubMed ID: 21480950)
1. The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men.
Van der Schueren BJ; Blanchard R; Murphy MG; Palcza J; De Lepeleire I; Van Hecken A; Depré M; de Hoon JN
Br J Clin Pharmacol; 2011 May; 71(5):708-17. PubMed ID: 21480950
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).
Sinclair SR; Kane SA; Van der Schueren BJ; Xiao A; Willson KJ; Boyle J; de Lepeleire I; Xu Y; Hickey L; Denney WS; Li CC; Palcza J; Vanmolkot FH; Depré M; Van Hecken A; Murphy MG; Ho TW; de Hoon JN
Br J Clin Pharmacol; 2010 Jan; 69(1):15-22. PubMed ID: 20078608
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca
Erdling A; Sheykhzade M; Edvinsson L
J Headache Pain; 2017 Dec; 18(1):61. PubMed ID: 28560541
[TBL] [Abstract][Full Text] [Related]
4. Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: results from a randomized study in patients with migraine.
Depré M; Macleod C; Palcza J; Behm M; de Lepeleire I; Han T; Panebianco D; Smith W; Blanchard R; Chodakewitz J; Murphy M; de Hoon J
Cephalalgia; 2013 Dec; 33(16):1292-301. PubMed ID: 23798725
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina.
Chaitman BR; Ho AP; Behm MO; Rowe JF; Palcza JS; Laethem T; Heirman I; Panebianco DL; Kobalava Z; Martsevich SY; Free AL; Bittar N; Chrysant SG; Ho TW; Chodakewitz JA; Murphy MG; Blanchard RL
Clin Pharmacol Ther; 2012 Mar; 91(3):459-66. PubMed ID: 22278333
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
Lynch JJ; Regan CP; Edvinsson L; Hargreaves RJ; Kane SA
J Cardiovasc Pharmacol; 2010 May; 55(5):518-21. PubMed ID: 20164785
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vivo effects of nitroglycerin and insulin on the aortic pressure waveform.
Westerbacka J; Tamminen M; Cockcroft J; Yki-Järvinen H
Eur J Clin Invest; 2004 Jan; 34(1):1-8. PubMed ID: 14984431
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.
Chan KY; Edvinsson L; Eftekhari S; Kimblad PO; Kane SA; Lynch J; Hargreaves RJ; de Vries R; Garrelds IM; van den Bogaerdt AJ; Danser AH; Maassenvandenbrink A
J Pharmacol Exp Ther; 2010 Sep; 334(3):746-52. PubMed ID: 20573757
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
[TBL] [Abstract][Full Text] [Related]
10. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
11. Relation of brachial artery reactivity to nitroglycerin and heart rate recovery following exercise in healthy male volunteers.
Girod JP; Garcia MJ; Saunders S; Drinko J; Brotman DJ
Am J Cardiol; 2005 Aug; 96(3):447-9. PubMed ID: 16054480
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled trial of telcagepant for the acute treatment of migraine.
Connor KM; Shapiro RE; Diener HC; Lucas S; Kost J; Fan X; Fei K; Assaid C; Lines C; Ho TW
Neurology; 2009 Sep; 73(12):970-7. PubMed ID: 19770473
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide-dependent vascular relaxation of rat aorta. An additional mechanism for nitroglycerin.
Booth BP; Tabrizi-Fard MA; Fung H
Biochem Pharmacol; 2000 Jun; 59(12):1603-9. PubMed ID: 10799659
[TBL] [Abstract][Full Text] [Related]
14. Direct vasodilation by transdermal administration of nitroglycerin: preliminary, randomized, placebo-controlled trial of nitroglycerin skin spray for premedication before artery puncture.
Tanitame K; Tani C; Nakamura Y; Yamasaki W; Ishikawa M; Kakizawa H; Date S; Awai K
Jpn J Radiol; 2012 May; 30(4):370-5. PubMed ID: 22302296
[TBL] [Abstract][Full Text] [Related]
15. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
Ho TW; Ho AP; Chaitman BR; Johnson C; Mathew NT; Kost J; Fan X; Aurora SK; Brandes JL; Fei K; Beebe L; Lines C; Krucoff MW
Headache; 2012 Feb; 52(2):224-35. PubMed ID: 22221076
[TBL] [Abstract][Full Text] [Related]
16. Differential localization and characterization of functional calcitonin gene-related peptide receptors in human subcutaneous arteries.
Edvinsson L; Ahnstedt H; Larsen R; Sheykhzade M
Acta Physiol (Oxf); 2014 Apr; 210(4):811-22. PubMed ID: 24330354
[TBL] [Abstract][Full Text] [Related]
17. Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation.
Pizzulli L; Hagendorff A; Zirbes M; Fehske W; Ewig S; Jung W; Lüderitz B
Am Heart J; 1996 Feb; 131(2):342-9. PubMed ID: 8579031
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship of sublingual nitroglycerin with brachial artery dilatation and change in central and peripheral augmentation index.
Oliver JJ; Bowler A; Beudeker Q; Cate Tt; Webb DJ
Clin Pharmacol Ther; 2005 Apr; 77(4):337-8. PubMed ID: 15903132
[No Abstract] [Full Text] [Related]
19. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
Ho TW; Connor KM; Zhang Y; Pearlman E; Koppenhaver J; Fan X; Lines C; Edvinsson L; Goadsby PJ; Michelson D
Neurology; 2014 Sep; 83(11):958-66. PubMed ID: 25107879
[TBL] [Abstract][Full Text] [Related]
20. Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study.
Behm MO; Blanchard RL; Murphy MG; Palcza JS; Harris DE; Butterfield KL; Smith WB; Preston RA; Chodakewitz JA; Krucoff MW
Headache; 2011 Jun; 51(6):954-60. PubMed ID: 21631478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
